All News

colitis.jpg

Low IBD Risk with IL-17 Inhibition

d Jack Cush, MD

Incident or worsening colitis is a rare complication of IL-17 inhibitor therapy; a real world study confirms very low rates of new IBD in patients starting secukinumab.

Read Article
Lungs ILD

Actemra FDA Approved for Systemic Sclerosis Interstitial Lung Disease

d Jack Cush, MD

Genentech announced Thursday that the US Food and Drug Administration approved tocilizumab (Actemra) for the treatment of Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD), specifically indicated for slowing the rate of decline in pulmonary function in adul

Read Article
Blinded by Noncompliance--New QD Clinic Suggestions on Optimizing Compliance in the Clinic https://t.co/tBnjBX68O8 https://t.co/uZ3aA7bnTJ

Links:

Dr. John Cush RheumNow ( View Tweet)
News Feature: Low IBD Risk with IL-17 Inhibition https://t.co/1kUH7sP755 https://t.co/DypPAcxB2a

Links:

Dr. John Cush RheumNow ( View Tweet)
Data Safety committee has closed recruitment to the colchicine arm in the RECOVERY trial a UK study of outcomes in COVID-19. Among 11162 enrolled pts (2178 deaths) those Rx w/ Colchicine had same 28 day mortality as usual care (20% vs. 19%) https://t.co/8gUc8LAZTp

Links:

Dr. John Cush RheumNow ( View Tweet)

Not surprisingly, a trial of repetitive transcranial magnetic stimulation failed to improve pain in fibromyalgia - next we can look forward to eye of newt N-of-1 trials. https://t.co/mEvvZhYgyR

Links:

Dr. John Cush RheumNow ( View Tweet)

We are just two weeks out from RheumNow Live. There's still time to register. Attend virtually or in-person. CME credits available. https://t.co/3zMtzt4t2H https://t.co/09Q5rRXsst

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumNow Podcast – Pounds of Prevention Dr. Jack Cush Reviews the news and journal reports from the past week on RheumNow. This podcast is sponsored by RheumNow Live. https://t.co/4XSBysiVFW https://t.co/PREqOkyuM9

Links:

Dr. John Cush RheumNow ( View Tweet)
Population study from Southern Norway shows the incidence of giant cell arteritis is not increasing. Over 13yrs, from pop of 300k they identified 206 GCA pts (72%females). Incidence rate of 16.8/100k per year. Mortality was not increased https://t.co/UA16uIuwD1

Links:

Dr. John Cush RheumNow ( View Tweet)

QD Clinic - RA and LFTs NAFLD, NASH and Risks with DMARDs and MTX https://t.co/LYV9WycEjz https://t.co/CMGtU4vclY

Links:

Dr. John Cush RheumNow ( View Tweet)
#RA associated interstifial lung dz has incidence of 1-5 per 1,000 PYs and prevalence as high as 67%; risk factors; age, male sex, Dz duration, CCP Abs; w/ age as best predictor of mortality. There is no clear drug interventions that helps RA-ILD https://t.co/zJvWqt0w6L

Links:

Dr. John Cush RheumNow ( View Tweet)

RheumNow Live is a powerful, interactive meeting delivered by researchers, educators, & clinicians. Sign up to attend virtually or in-person today. https://t.co/SvLpwNYh9c

Links:

Dr. John Cush RheumNow ( View Tweet)

Why it's safe to come to RheumNow Live. Lessons learned from restaurants and flying. https://t.co/R0eYO2GiPd https://t.co/E9vPjzUTgb

Links:

Dr. John Cush RheumNow ( View Tweet)
News Feature: Actemra FDA Approved for Systemic Sclerosis Interstitial Lung Disease https://t.co/6A4muejeH9 https://t.co/xQbIoEEscv

Links:

Dr. John Cush RheumNow ( View Tweet)
Download available--Difficult RA Defined https://t.co/6WGMEiwiUk

Links:

Dr. John Cush RheumNow ( View Tweet)

RheumNow podcast now available! Listen on SoundCloud and Apple/Android podcasts. https://t.co/P6kaqZP0PJ https://t.co/BPQ5Ey7d0r

Links:

Dr. John Cush RheumNow ( View Tweet)
"... think what others won’t think; go where others won’t go; do what others won’t do; and be what others want to be." - Phil knight

Dr. John Cush RheumNow ( View Tweet)

News Feature: Baricitinib Therapy in Covid-19 Pneumonia https://t.co/b3tsLcoXay https://t.co/tjqkk1RLFZ

Links:

Dr. John Cush RheumNow ( View Tweet)
Download available--Arthritis Myths https://t.co/2Kxpou4Fbz

Links:

Dr. John Cush RheumNow ( View Tweet)

We have a robust agenda planned for RheumNow Live. Have you registered yet? https://t.co/3zMtzt4t2H https://t.co/iLNj8XEu4X

Links:

Dr. John Cush RheumNow ( View Tweet)
×